Chemotherapy prolongs survival after surgery for gastric cancerBMJ 2007; 335 doi: http://dx.doi.org/10.1136/bmj.335.7627.962-c (Published 08 November 2007) Cite this as: BMJ 2007;335:962
S-1 is an oral chemotherapy agent that combines a prodrug of fluorouracil with two enzyme inhibitors—one to stop the active drug being degraded and the other to help protect against gastrointestinal toxicity. Japanese oncologists use it to treat advanced gastric cancer, and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial